Aparna Khanna

Title: The Innovative Contributions of Aparna Khanna

Introduction

Aparna Khanna is a notable inventor based in Navi Mumbai, India. She has made significant contributions to the field of biotechnology, particularly in the area of human embryonic stem cell research. Her work has implications for regenerative medicine and cellular therapies.

Latest Patents

Aparna Khanna holds a patent for the establishment of a human embryonic stem cell line using mammalian cells. This patent, which includes 1 patent, discloses purified preparations of human embryonic stem cells with specific population characteristics. The preparation is characterized by the positive expression of pluripotent cell surface markers such as SSEA-4, TRA-1-60, and TRA-1-81, among others. The cells are negative for lineage-specific markers and exhibit high telomerase activity, allowing them to proliferate in an undifferentiated state for over 40 passages. The embryonic stem cell line, named Relicell™ hES1, retains the ability to differentiate into various cell and tissue types derived from all three embryonic germ layers.

Career Highlights

Aparna Khanna is currently associated with Reliance Life Sciences Pvt. Ltd., where she continues her research and development in stem cell technology. Her work has positioned her as a key figure in the advancement of stem cell applications in medicine.

Collaborations

Aparna has collaborated with several professionals in her field, including Arundhati Mandal and Shabari Pradeep Tipnis. These collaborations have further enriched her research and contributed to the success of her projects.

Conclusion

Aparna Khanna's innovative work in the field of human embryonic stem cells showcases her dedication to advancing medical science. Her contributions are paving the way for future breakthroughs in regenerative medicine.